Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Tenet Healthcare (THC) is increasingly focused on hospital operations and ambulatory services across the United States. The company has demonstrated strong financial management by increasing its cash reserves, actively retiring its debt, and implementing share buybacks. With a price-to-earnings ratio of 11x and a price-to-book ratio of 3.1x, Tenet shows attractive valuation metrics. Additionally, it supports a robust return on equity (ROE) of 110%. Analysts have set a price target of $173.53, indicating a potential upside of 25%, and they recommend placing a stop-loss at $120 due to the absence of dividends, as the yield remains at 0%. Overall, these financial indicators point to a promising outlook for Tenet Healthcare.
Tenet Healthcare is a American stock, trading under the symbol THC-N on the New York Stock Exchange (THC). It is usually referred to as NYSE:THC or THC-N
In the last year, 1 stock analyst published opinions about THC-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Tenet Healthcare.
Tenet Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for Tenet Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Tenet Healthcare published on Stockchase.
On 2025-04-24, Tenet Healthcare (THC-N) stock closed at a price of $121.9.
Our PAST TOP PICK with THC has triggered its stop at $120. To remain disciplined, we recommend covering the position at this time.